300314 Ningbo David Medical Device
- 11.37
- -0.16-1.39%
Ningbo David Medical Device News
David Medical Device's Unit Gets Certificate for Electric Anorectal Stapler
Ningbo David Medical Device (SHE:300314) unit, Ningbo Weirkaidi Medical Equipment, received a medical device registration certificate from the food and drug regulator of China's Zhejiang Province for
David Healthcare (300314.SZ): Valkady products obtained medical device registration certificate
On May 16, Ge Longhui Medical (300314.SZ) announced that the wholly-owned subsidiary of the company, Ningbo Vivacity Medical Devices Co., Ltd. (hereinafter referred to as “Virkaidi”), recently received a “Medical Device Registration Certificate” issued by the Zhejiang Drug Administration to use an electric anorectal stapler for single use.
Ningbo David Medical Device (SZSE:300314) Jumps 24% This Week, Though Earnings Growth Is Still Tracking Behind Five-year Shareholder Returns
Generally speaking the aim of active stock picking is to find companies that provide returns that are superior to the market average. Buying under-rated businesses is one path to excess returns. For
David Healthcare (300314.SZ): Net profit of 38.1072 million yuan in the first quarter decreased by 23.81% year-on-year
On April 19, Ge Longhui (300314.SZ) released its report for the first quarter of 2024. Operating income for the reporting period was 155 million yuan, down 1.61% year on year; net profit attributable to shareholders of listed companies was 38.1072 million yuan, down 23.81% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 394.438 million yuan, down 11.14% year on year; basic earnings per share were 0.1323 yuan.
Ningbo David Medical Device's (SZSE:300314) Promising Earnings May Rest On Soft Foundations
Ningbo David Medical Device Co., Ltd. (SZSE:300314) announced strong profits, but the stock was stagnant. Our analysis suggests that shareholders have noticed something concerning in the numbers.
David Medical (300314.SZ): Pediatric obstetrics care equipment has now entered more than 600 of the top three hospitals in China
Gelonghui, April 16 | David Medical (300314.SZ) said at an investor relations event that the company's pediatric obstetrics care equipment has now entered more than 600 domestic hospitals, has agents in more than 30 provinces, cities and autonomous regions, and provides technology, products and services to more than 140 countries and regions around the world; the company's minimally invasive surgical instruments have entered more than 400 domestic hospitals, and the foreign market covers 83 countries and regions. Currently, there are a total of 29 research projects. For details, please refer to the company's 2023 report.
David Healthcare (300314.SZ) announced its 2023 annual results, with net profit of 148 million yuan, an increase of 51.62%
David Healthcare (300314.SZ) released its 2023 annual report. The company's revenue was 618 million yuan...
David Healthcare (300314.SZ): As of February 29, 2024, the total number of shareholders of the company is about 16,300
On March 5, Ge Longhui | David Healthcare (300314.SZ) said on the investor interactive platform that as of February 29, 2024, the total number of shareholders of the company was about 16,300.
David Medical (300314.SZ): Currently, Vercady endoscopic staplers have entered more than 300 domestic hospitals
On March 5, Ge Longhui | David Medical (300314.SZ) said on the investor interactive platform that at present, Virkaidi endoscopic staplers have entered more than 300 domestic hospitals, mainly in the top three hospitals.
David Healthcare (300314.SZ): Wholly-owned subsidiary's application for medical device registration accepted
Gelonghui, Feb. 1, Davie Medical (300314.SZ) announced that Ningbo Vivacity Medical Devices Co., Ltd. (“Vercedi”), a wholly-owned subsidiary of the company, recently obtained 2 “Acceptance Notices” issued by the Zhejiang Drug Administration. The acceptance numbers are: 20244003283 for drug acceptance and 20244003467 for drug acceptance.
Positive Sentiment Still Eludes Ningbo David Medical Device Co., Ltd. (SZSE:300314) Following 27% Share Price Slump
Ningbo David Medical Device Co., Ltd. (SZSE:300314) shareholders won't be pleased to see that the share price has had a very rough month, dropping 27% and undoing the prior period's positive performan
David Healthcare (300314.SZ): As of January 10, 2024, the total number of shareholders of the company is about 16,000
On January 12, Ge Longhui | David Healthcare (300314.SZ) said on the investor interactive platform that as of January 10, 2024, the total number of shareholders of the company was about 16,000.
David Healthcare (300314.SZ) and Valkydy passed the high-tech enterprise certification
Gelonghui, December 29丨David Medical (300314.SZ) announced that the company and its wholly-owned subsidiary Ningbo Vierkaidi Medical Devices Co., Ltd. (“Velkady”) received the “Notice on the Filing of the First Batch of High-tech Enterprises in the 2023 Accreditation Report” issued by the National High-tech Enterprise Certification and Management Leading Group Office. The company and Welkady were recognized as high-tech enterprises. The certificate numbers are GR202333102141 and GR202333102669, respectively. The certificate numbers are GR202333102669, respectively. May 8th, valid for three years
David Medical (300314.SZ) subsidiary obtains “disposable circumcision stapler” medical device registration certificate
David Medical (300314.SZ) issued an announcement. Ningbo Welkaidi Medical Devices Co., Ltd., a wholly-owned subsidiary of the company...
David Healthcare (300314.SZ) subsidiary's application for a medical device registration was accepted
David Medical (300314.SZ) announced that Ningbo Wilkedi Medical Devices Co., Ltd., a wholly-owned subsidiary of the company (simplified...
David Healthcare (300314.SZ): At present, the company's overseas business has achieved steady development
Gelonghui, November 22|David Healthcare (300314.SZ) recently stated during a survey from institutional investors that at present, the company's overseas business has achieved steady development, and will continue to pay attention to the expansion of overseas business in the future, taking into account the market development of the industry and its own actual situation, and actively develop related business overseas layout.
David Healthcare (300314.SZ): The company's production and operation maintained smooth operation in the first three quarters
Gelonghui, November 22|David Healthcare (300314.SZ) recently stated during a survey from institutional investors that the company's production and operation maintained smooth operation in the first three quarters. The first three quarters achieved revenue of 459 million yuan, a year-on-year increase of 31.21%. Net profit of the mother was 123 million yuan, an increase of 61.70% over the previous year. After deducting non-net profit of 106 million yuan, a year-on-year increase of 72.33%.
Ningbo David Medical Device's (SZSE:300314) Five-year Earnings Growth Trails the 12% YoY Shareholder Returns
It hasn't been the best quarter for Ningbo David Medical Device Co., Ltd. (SZSE:300314) shareholders, since the share price has fallen 18% in that time. But that doesn't change the fact that the re
David Healthcare (300314.SZ) released results for the first three quarters, with net profit of 123 million yuan, an increase of 61.70%
David Healthcare (300314.SZ) released its report for the third quarter of 2023, and achieved revenue of 4.5 in the first three quarters...
[Instant Analysis of BT Financial Report] David Healthcare 2023 Interim Report: Revenue and Net Profit Increased Sharply, and Cash Flow Performance Remarkable
David Healthcare (stock code: 300314)'s 2023 interim report has been published. From this, we can see the company's performance in various financial data. First, let's take a look at David Healthcare's revenue. Revenue for the reporting period was 317,308,737.59 yuan, an increase of 51.82% compared to 209,007,798.26 yuan after adjustments for the same period last year. This indicates that the company's business scale is expanding, and its market share is likely to increase. Next, let's take a look at David Healthcare's net profit. Net profit attributable to shareholders of listed companies for the reporting period was 91,7
Analysis
Price Target
No Data
